Abstract
This study probes the function and mechanism of lymphocyte-specific protein 1 (LSP1) in glioblastoma pathogenesis. According to the data acquired from TCGA, Oncomine and GEO databases, the expression and prognostic value of LSP1 and miR-920 in glioblastoma patients were analyzed. The expression levels of LSP1 in U251 and A172 cell lines were analyzed by qRT-PCR and western blotting. CCK8, colony formation and transwell assays were utilized to test glioblastoma cell malignant abilities. Furthermore, the associations between LSP1 and miR-920 were indentified by bioinformatics analysis and rescue assays. Moreover, the protein expression levels of p-JAK2, JAK2, p-STAT5 and STAT5, as the hallmark of JAK/STAT5 signaling, were detected by western blotting. The observations showed that LSP1 was highly augmented in glioblastoma samples. Additionally, up-regulation of LSP1 was associated with a unfavorable prognosis in glioblastoma patients. Biological experiments revealed that depletion of LSP1 significantly suppressed the proliferation, invasion and migration of U251 and A172 cells. MiR-920, as an upstream regulator of LSP1, negatively modulated LSP1 expression and promoted U251 cells malignant behaviors after miR-920 inhibitor treatment. However, together knockdown LSP1 and miR-920 inhibited these effects. Moreover, the expression levels of p-JAK2 and p-STAT5 were increased or decreased in U251 cells after transfection of miR-920 inhibitor or si-LPS1. Taken together, miR-920 might blocked the malignant development of glioblastoma cells, which is possibly realized by targeting LSP1 and modulation of JAK/STAT5 pathway. These findings implied that miR-920/LSP1 was a potential therapeutic target for glioblastoma treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baumgartner C, Cerny-Reiterer S, Sonneck K, Mayerhofer M, Gleixner KV, Fritz R, Kerenyi M, Boudot C, Gouilleux F, Kornfeld JW, Sillaber C, Moriggl R, Valent P (2009) Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V. Am J Pathol 175:2416–2429. https://doi.org/10.2353/ajpath.2009.080953
Buettner R, Mora LB, Jove R (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clinical cancer research : an official journal of the American Association for Cancer Research 8:945–954
Cajina M, Nattini M, Song D, Smagin G, Jorgensen EB, Chandrasena G, Bundgaard C, Toft DB, Huang X, Acher F et al (2014) Qualification of LSP1-2111 as a brain penetrant group III metabotropic glutamate receptor Orthosteric agonist. ACS Med Chem Lett 5:119–123. https://doi.org/10.1021/ml400338f
Chen H, Qi X, Qiu P, Zhao J (2015) Correlation between LSP1 polymorphisms and the susceptibility to breast cancer. Int J Clin Exp Pathol 8:5798–5802
Chen J, Hou C, Zheng Z, Lin H, Lv G, Zhou D (2019) Identification of secreted phosphoprotein 1 (SPP1) as a prognostic factor in lower-grade gliomas. World neurosurgery 130:e775–e785. https://doi.org/10.1016/j.wneu.2019.06.219
Chi D, Zhang W, Jia Y, Cong D, Hu S (2019) Spalt-like transcription factor 1 (SALL1) gene expression inhibits cell proliferation and cell migration of human Glioma cells through the Wnt/beta-catenin signaling pathway. Medical Science Monitor Basic Research 25:128–138. https://doi.org/10.12659/MSMBR.915067
Childs EJ, Chaffee KG, Gallinger S, Syngal S, Schwartz AG, Cote ML, Bondy ML, Hruban RH, Chanock SJ, Hoover RN, Fuchs CS, Rider DN, Amundadottir LT, Stolzenberg-Solomon R, Wolpin BM, Risch HA, Goggins MG, Petersen GM, Klein AP (2016) Association of Common Susceptibility Variants of pancreatic Cancer in higher-risk patients: a PACGENE study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 25:1185–1191. https://doi.org/10.1158/1055-9965.EPI-15-1217
Feng J, Guo J, Wang JP, Chai BF (2020) MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression. European Review for Medical and Pharmacological Sciences 24:3665–3673. https://doi.org/10.26355/eurrev_202004_20829
Guo Y, Hong W, Wang X, Zhang P, Körner H, Tu J, Wei W (2019) MicroRNAs in microglia: how do MicroRNAs affect activation, inflammation, polarization of microglia and mediate the interaction between microglia and Glioma? Front Mol Neurosci 12:125. https://doi.org/10.3389/fnmol.2019.00125
Haricharan S, Dong J, Hein S, Reddy JP, Du Z, Toneff M, Holloway K, Hilsenbeck SG, Huang S, Atkinson R et al (2013) Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy. eLife 2:e00996. https://doi.org/10.7554/eLife.00996
Hashemi M, Fallah A, Aghayan HR, Arjmand B, Yazdani N, Verdi J, Ghodsi SM, Miri SM, Hadjighassem M (2016) A new approach in gene therapy of Glioblastoma Multiforme: human olfactory Ensheathing cells as a novel carrier for suicide gene delivery. Mol Neurobiol 53:5118–5128. https://doi.org/10.1007/s12035-015-9412-y
Hossain M, Qadri SM, Xu N, Su Y, Cayabyab FS, Heit B, Liu L (2015) Endothelial LSP1 modulates extravascular neutrophil Chemotaxis by regulating nonhematopoietic vascular PECAM-1 expression. J Immunol 195:2408–2416. https://doi.org/10.4049/jimmunol.1402225
Hu H, Mu Q, Bao Z, Chen Y, Liu Y, Chen J, Wang K, Wang Z, Nam Y, Jiang B, Sa JK, Cho HJ, Her NG, Zhang C, Zhao Z, Zhang Y, Zeng F, Wu F, Kang X, Liu Y, Qian Z, Wang Z, Huang R, Wang Q, Zhang W, Qiu X, Li W, Nam DH, Fan X, Wang J, Jiang T (2018) Mutational landscape of secondary Glioblastoma guides MET-targeted trial in brain tumor. Cell 175:1665–1678 e1618. https://doi.org/10.1016/j.cell.2018.09.038
Hwang SH, Jung SH, Lee S, Choi S, Yoo SA, Park JH, Hwang D, Shim SC, Sabbagh L, Kim KJ et al (2015) Leukocyte-specific protein 1 regulates T-cell migration in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America 112:E6535–E6543. https://doi.org/10.1073/pnas.1514152112
Ihle JN, Kerr IM (1995) Jaks and stats in signaling by the cytokine receptor superfamily. Trends in genetics : TIG 11:69–74. https://doi.org/10.1016/s0168-9525(00)89000-9
Jin SY, Choi JS, Choi YL, Choi YL, Kim DH, Lee SH (2015) Identification of leukocyte-specific protein 1-positive cells: a clue to the cell of origin and a marker for the diagnosis of dermatofibroma. Ann Dermatol 27:157–162. https://doi.org/10.5021/ad.2015.27.2.157
Jovčevska I (2019) Genetic secrets of long-term glioblastoma survivors. Bosn J Basic Med Sci 19:116–124. https://doi.org/10.17305/bjbms.2018.3717
Keller A, Wingelhofer B, Peter B, Bauer K, Berger D, Gamperl S, Reifinger M, Cerny-Reiterer S, Moriggl R, Willmann M, Valent P, Hadzijusufovic E (2018) The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma. Vet Comp Oncol 16:55–68. https://doi.org/10.1111/vco.12311
Kim YJ, Lee DJ, Park CK, Kim IA (2019) Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era. Neurosurg Rev 42:937–950. https://doi.org/10.1007/s10143-018-01071-3
Koral K, Paranjpe S, Bowen WC, Mars W, Luo J, Michalopoulos GK (2015) Leukocyte-specific protein 1: a novel regulator of hepatocellular proliferation and migration deleted in human hepatocellular carcinoma. Hepatology 61:537–547. https://doi.org/10.1002/hep.27444
Lim U, Kocarnik JM, Bush WS, Matise TC, Caberto C, Park SL, Carlson CS, Deelman E, Duggan D, Fesinmeyer M, Haiman CA, Henderson BE, Hindorff LA, Kolonel LN, Peters U, Stram DO, Tiirikainen M, Wilkens LR, Wu C, Kooperberg C, le Marchand L (2014) Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium. PLoS One 9:e89791. https://doi.org/10.1371/journal.pone.0089791
Liu DK, Wei YJ, Guo Y, Wang J, Wang GH (2018) MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2. European Review for Medical and Pharmacological Sciences 22:2343–2350. https://doi.org/10.26355/eurrev.201804.14825
Mohr AM, Mott JL (2015) Overview of microRNA biology. Semin Liver Dis 35:3–11. https://doi.org/10.1055/s-0034-1397344
Nan Y, Guo H, Guo L, Wang L, Ren B, Yu K, Huang Q, Zhong Y (2018) MiRNA-451 inhibits Glioma cell proliferation and invasion through the mTOR/HIF-1α/VEGF signaling pathway by targeting CAB39. Human gene therapy Clinical development 29:156–166. https://doi.org/10.1089/humc.2018.133
Nie X, Su Z, Yan R, Yan A, Qiu S, Zhou Y (2019) MicroRNA-562 negatively regulated c-MET/AKT pathway in the growth of glioblastoma cells. OncoTargets and therapy 12:41–49. https://doi.org/10.2147/OTT.S186701
Petrescu GED, Sabo AA, Torsin LI, Calin GA, Dragomir MP (2019) MicroRNA based theranostics for brain cancer: basic principles. Journal of Experimental & Clinical Cancer Research : CR 38:231. https://doi.org/10.1186/s13046-019-1180-5
Poorhosseini SM, Hashemi M, Alipour Olyaei N, Izadi A, Moslemi E, Ravesh Z, Hashemi-Gorji F, Kheiri HR, Yassaee VR (2016) New gene profiling in determination of breast Cancer recurrence and prognosis in Iranian women. Asian Pacific journal of cancer prevention : APJCP 17:155–160
Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z (2015) Maintenance therapy with tumor-treating fields plus Temozolomide vs Temozolomide alone for Glioblastoma: a randomized clinical trial. Jama 314:2535–2543. https://doi.org/10.1001/jama.2015.16669
Tang J, Li H, Luo J, Mei H, Peng L, Li X (2016) The LSP1 rs3817198 T > C polymorphism contributes to increased breast cancer risk: a meta-analysis of twelve studies. Oncotarget 7:63960–63967. https://doi.org/10.18632/oncotarget.11741
Wang Z, Bunting KD (2013) STAT5 in hematopoietic stem cell biology and transplantation. Jak-stat 2:e27159. https://doi.org/10.4161/jkst.27159
Wang BS, Liu Z, Xu WX, Sun SL (2014) Functional polymorphisms in microRNAs and susceptibility to liver cancer: a meta-analysis and meta-regression. Genetics and Molecular Research : GMR 13:5426–5440. https://doi.org/10.4238/2014.July.24.22
Wang F, Zheng Z, Guan J, Qi D, Zhou S, Shen X, Wang F, Wenkert D, Kirmani B, Solouki T, Fonkem E, Wong ET, Huang JH, Wu E (2018) Identification of a panel of genes as a prognostic biomarker for glioblastoma. EBioMedicine 37:68–77. https://doi.org/10.1016/j.ebiom.2018.10.024
Wang S, Fan Y, Xu Y, Zhang L, Cai L, Lv B (2019) GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells. Experimental and therapeutic medicine 18:1315–1322. https://doi.org/10.3892/etm.2019.7670
Wong KK, Rostomily R, Wong STC (2019) Prognostic gene discovery in Glioblastoma patients using deep learning. Cancers 11. https://doi.org/10.3390/cancers11010053
Xin S, Huang K, Zhu XG (2019) Non-coding RNAs: regulators of glioma cell epithelial-mesenchymal transformation. Pathol Res Pract 215:152539. https://doi.org/10.1016/j.prp.2019.152539
Yan D, Hao C, Xiao-Feng L, Yu-Chen L, Yu-Bin F, Lei Z (2018a) Molecular mechanism of notch signaling with special emphasis on microRNAs: implications for glioma. J Cell Physiol 234:158–170. https://doi.org/10.1002/jcp.26775
Yan W, Yang W, Liu Z, Wu G (2018b) Characterization of microRNA expression in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). OncoTargets and therapy 11:4701–4709. https://doi.org/10.2147/ott.s169233
Zhang H, Wang Y, Liu Z, Yao B, Dou C, Xu M, Li Q, Jia Y, Wu S, Tu K, Liu Q (2016) Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. FEBS open bio 6:1227–1237. https://doi.org/10.1002/2211-5463.12139
Funding
This work was supported by the Science and Technology Development Plan of Jinan city (No: 201805087) and the Key Research and Development Plan of Shandong province (No: 2016GSF201065).
Author information
Authors and Affiliations
Contributions
All authors contributed toward data analysis, drafting and critically revising the paper and agree to be accountable for all aspects of the work. And authors final approval of the version to be published.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cong, P., Hou, HY., Wei, W. et al. MiR-920 and LSP1 co-regulate the growth and migration of glioblastoma cells by modulation of JAK2/STAT5 pathway. J Bioenerg Biomembr 52, 311–320 (2020). https://doi.org/10.1007/s10863-020-09848-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-020-09848-2